Incremental hemodialysis and vascular access complications: a 12-year experience in a hospital hemodialysis unit
Journal of Nephrology · 2024
DOI: 10.1007/s40620-024-01932-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nephrology, 2024. Verfasst von Milagros Fernández Lucas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. milagros.fernan…. Hauptthemen laut MEDLINE: Renal Dialysis, Arteriovenous Shunt, Surgical. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Incremental hemodialysis (HD) is considered a valid alternative for patients with residual kidney function. Evidence concerning its effect on vascular access is scarce. We present our 12-year experience of an incremental hemodialysis program with the aim of evaluating survival and complications of arteriovenous fistula in these patients compared to the thrice-weekly scheme. METHODS: From January 1st, 2006 to December 31st, 2017, 220 incident patients started hemodialysis, 132 (60%) of whom began hemodialysis with two sessions per week and 88 (40%) with three sessions per week. Demographic and clinical variables were assessed at the start of treatment. Data regarding arteriovenous fistula survival and complications were collected. RESULTS: Both groups had similar baseline sociodemographic and clinical characteristics. A total of 188 (85%) patients were dialyzed with an arteriovenous fistula during follow-up. Eighty-three patients had one or more fistula complications, with no differences between incremental and conventional groups (p = 0.55). Fistula survival rates showed no significant difference between the two groups, whether analyzed from the date of fistula creation (Log Rank p = 0.810) or from the date of initial fistula cannulation (Log Rank p = 0.695). CONCLUSIONS: We found no differences in arteriovenous fistula survival or complication rate between patients who started HD with an incremental versus a conventional treatment scheme. Randomized controlled clinical trials may be warranted to achieve a higher degree of evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nephrology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. milagros.fernandez@salud.madrid.org.
- Alcalá de Henares University, Madrid, Spain. milagros.fernandez@salud.madrid.org.
- Nephrology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Zitieren
APA
Fernández Lucas, M., Piris González, M., Díaz Domínguez, M. E., Collado Alsina, A., & Rodríguez Mendiola, N. M. (2024). Incremental hemodialysis and vascular access complications: a 12-year experience in a hospital hemodialysis unit. Journal of Nephrology. https://doi.org/10.1007/s40620-024-01932-9
Vancouver
Fernández Lucas M, Piris González M, Díaz Domínguez ME, Collado Alsina A, Rodríguez Mendiola NM. Incremental hemodialysis and vascular access complications: a 12-year experience in a hospital hemodialysis unit. Journal of Nephrology. 2024. doi:10.1007/s40620-024-01932-9
BibTeX
@article{FernndezLucas2024,
author = {Fernández Lucas, Milagros and Piris González, Marcos and Díaz Domínguez, Martha Elizabeth and Collado Alsina, Andrea and Rodríguez Mendiola, Nuria María},
title = {Incremental hemodialysis and vascular access complications: a 12-year experience in a hospital hemodialysis unit},
journal = {Journal of Nephrology},
year = {2024},
doi = {10.1007/s40620-024-01932-9}
}
EUVIMED